1.
Erlotinib as the Second-line Treatment for NSCLC Patients of Stage Ⅲb/Ⅳ
厄洛替尼二线治疗非小细胞肺癌临床疗效观察
2.
Clinical observation of efficacy of pemetrexed as second-line therapy in treatment of patients with advanced non-small-cell lung cancer
培美曲塞二钠二线治疗晚期非小细胞肺癌近期疗效观察
3.
The Effect of Gemcitabine on Second- line Treatment for Patients with Advanced Soft Tissue Sarcomas;
健择在晚期软组织肉瘤二线治疗中的作用
4.
Effect of IP as second-line chemotherapy for patients with relapsed small cell lung cancer
IP方案二线治疗复发性小细胞肺癌的临床观察
5.
Combination of Paclitaxel and Capecitabine as Second-line Chemotherapy in the Treatment of 38 Cases with Advanced Gastric Cancer
紫杉醇联合卡培他滨二线治疗晚期胃癌38例
6.
Comparison of docetaxel and Iressa in the treatment of non-small-cell lung cancer patients
TP方案和易瑞沙二线治疗非小细胞肺癌的比较
7.
Gefitinib in the treatment of advanced non-small cell Lung cancer failed to prioy chemotherapy
吉非替尼二线治疗晚期非小细胞肺癌临床研究
8.
Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer
伊立替康联合卡培他滨二线治疗晚期胃癌
9.
Clinical Observation of Weekly Irinotecan as Second-Line Treatment of Patients with Metastatic Gastrointestinal Cancer
周剂量伊立替康二线治疗晚期转移性胃肠癌疗效观察
10.
Clinical study of gefitinib on the first or second line to treat old age advanced NSCLC
吉非替尼一线、二线治疗老年晚期非小细胞肺癌比较研究
11.
Significance of Serum VEGF in Lung Cancer and Angiogenic Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer;
VEGF在肺癌中的临床意义及抗血管生成药物二线治疗晚期NSCLC
12.
Clinical observation of pemetrexed for the treatment of 26 elderly patients with advanced non-small cell lung cancer as a second-line regimen
培美曲塞单药二线治疗26例老年晚期非小细胞肺癌临床观察
13.
Evaluation of pemetrexed in treating advanced non-small cell Lung cancer
培美曲塞二线治疗晚期非小细胞肺癌的临床评价
14.
The clinical observation of gemcitabine combined with cisplatin as second-line chemotherapy for non-small cell lung cancer (NSCLC)
吉西他滨联合顺铂方案二线治疗晚期非小细胞肺癌的临床观察
15.
Efficacy of pemetrexed combined with nedaplatin in treatment of non-small cell lung cancer patients
培美曲塞联合奈达铂二线治疗晚期非小细胞肺癌临床观察
16.
Clinical analysis of treatment of 40 non-small cell lung cancer patients with gefitinib
吉非替尼二线治疗晚期非小细胞肺癌40例临床分析
17.
Second-line therapy of erlotinib in advanced non-small cell lung cancer
厄洛替尼二线治疗晚期非小细胞肺癌的临床观察
18.
The combination of capecitabine and irinotecan in treating 38 cases of advanced colorectal cancer as second-line chemtherapy regimen
伊立替康联合卡培他滨二线治疗38例晚期结直肠癌的临床观察